P.3.a.030 A 6-month, double-blind trial of ziprasidone plus a mood stabilizer in subjects with bipolar I disorder

Eduard Vieta; Charles L. Bowden; Kathleen Ice; Jeffrey H. Schwartz; P. Wang; M. Versavel; Onur N. Karayal

doi:10.1016/s0924-977x(09)70785-0

Related publications

Article2009

A 6-month, Randomized, Placebo-controlled, Double Blind Trial of Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder

Eduard Vieta, Charles L. Bowden, Kathleen Ice, Oksana Gurtovaya, Jeffrey H. Schwartz, P. Wang

Article2010

Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder

Charles L. Bowden, Eduard Vieta, Kathleen Ice, Jeffrey H. Schwartz, Paul P. Wang, Mark Versavel

Article2011

Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profiles

David E. Kemp, Onur N. Karayal, Joseph R. Calabrese, Gary S. Sachs, Elizabeth Pappadopulos, Kathleen Ice, Cynthia Siu, Eduard Vieta

Article2012

A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder

Eduard Vieta, Stuart Montgomery, Ahmad Hatim Sulaiman, Rodrigo Córdoba, Benedicte Huberlant, Lupe Martínez, A. Schreiner

Article2022

T126. ADVANCING PHARMACOGENOMICS OF ANTICONVULSANT MOOD STABILIZER RESPONSE IN BIPOLAR DISORDER THROUGH THE MOOD STABILIZER GENOMICS (MOSTGEN) CONSORTIUM

Joanna M. Biernacka, Ada Man‐Choi Ho, Brandon J. Coombes, Susan L. McElroy, Alfredo Cuellar Barboza, Miguel A. Prieto, Eduard Vieta, Melvin G. McInnis, Bernhard T. Baune, Thomas G. Schulze, Boris Chaumette, Mirko Manchia, Alessandro Serretti, Martin Alda, Mark A. Frye